How Much Is Zepbound With the Savings Card? The 2026 Real-Price Breakdown

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Zepbound with the Lilly savings card costs $25 per month for eligible patients with commercial insurance, reducing copays up to $563 per fill
• The savings card excludes Medicare, Medicaid, TRICARE, and patients without insurance coverage, leaving approximately 40% of potential users ineligible
• Without the savings card, insured patients pay $50 to $550 monthly depending on formulary tier, while cash price runs $1,060 to $1,350 per month
• The card expires after 13 uses or when cumulative savings reach $7,319, whichever comes first, requiring patients to plan for post-card costs

Direct answer (40-60 words)

Zepbound with the Lilly savings card costs $25 per month for patients with commercial insurance that covers the medication. The card reduces copays by up to $563 per fill but excludes government insurance beneficiaries. Without the card, insured copays range from $50 to $550 monthly, and cash price is $1,060 to $1,350.

Table of contents

1. The 30-second answer
2. How the Lilly savings card actually works
3. Real patient cost scenarios (6 insurance types)
4. The five eligibility requirements most people miss
5. What happens when you hit the savings cap
6. Zepbound cash price by dose (2026)
7. The three-tier cost structure explained
8. Savings card vs patient assistance program (PAP)
9. Why 40% of patients don't qualify for the card
10. The compounded tirzepatide alternative
11. How to calculate your specific cost in 10 minutes
12. What most articles get wrong about the savings card
13. FAQ

How the Lilly savings card actually works

The Lilly savings card is not a discount card. It's a manufacturer copay offset program that only activates after your insurance processes the claim.

Here's the sequence at the pharmacy counter:

1. The pharmacist runs your insurance card first
2. Your insurance returns a copay amount (say, $300)
3. The pharmacist applies the savings card second
4. The savings card reduces your copay to $25 (Lilly pays the pharmacy the $275 difference)
5. You pay $25

The card doesn't replace insurance. It modifies what you owe after insurance does its calculation. This single architectural fact explains why the card doesn't work for uninsured patients, Medicare beneficiaries, or anyone whose plan denies coverage entirely.

The maximum benefit per fill is $563. If your insurance copay is $588, the card brings it down to $25. If your copay is $700, the card brings it down to $137 (the $563 maximum reduction applied).

The card has two termination conditions, whichever comes first:

• 13 uses (roughly 13 months of treatment)
• $7,319 in cumulative savings

For most patients paying $25 per month, the 13-use limit hits first. For patients with very high copays where the card applies the maximum $563 reduction each time, the dollar cap hits around month 13.

Real patient cost scenarios (6 insurance types)

Scenario 1: Employer PPO with Tier 3 coverage. Patient works for a mid-sized tech company. United Healthcare PPO. Zepbound is on Tier 3 (non-preferred brand) with $250 copay after deductible. Deductible is $2,000, met by March. With savings card: $25 per month April through December. Without savings card: $250 per month.

Scenario 2: High-deductible health plan (HDHP). Patient has an employer HDHP with $5,000 deductible. Zepbound negotiated rate is $1,150. Until deductible is met (typically June-August for most patients), she pays full $1,150 per fill. Savings card reduces this to $587 per fill (the $563 maximum reduction). After deductible, copay drops to $100, savings card brings it to $25.

Scenario 3: Marketplace gold plan. Patient bought a gold plan through Healthcare.gov. Zepbound is covered with prior authorization on Tier 4 (specialty) at 25% coinsurance. Negotiated price is $1,200. Coinsurance is $300. With savings card: $25. Without: $300. The $2,500 deductible must be met first, during which patient pays full negotiated rate minus the $563 card reduction.

Scenario 4: Medicare Part D. Patient is 68, retired, on a Medicare Advantage plan with Part D prescription coverage. Zepbound is covered for type 2 diabetes with $400 specialty tier copay. Lilly savings card does not apply to Medicare. Monthly cost: $400 (sometimes higher in the coverage gap/donut hole). No manufacturer assistance available.

Scenario 5: Medicaid. Patient has state Medicaid. Coverage for Zepbound varies by state. In states that cover it, prior authorization is required and copay is typically $0 to $8. Savings card doesn't apply (government insurance exclusion), but the baseline copay is already minimal. In states that don't cover Zepbound for weight loss, patient pays full cash price with no savings card option.

Scenario 6: No insurance. Patient is self-employed, between coverage. Cash price at major retail pharmacies is $1,060 to $1,350 per month. Lilly savings card requires active insurance coverage, so it doesn't apply. GoodRx coupons bring cash price down to $950 to $1,150. Patient assistance program (PAP) is the only Lilly option for qualifying low-income uninsured patients.

The pattern: the savings card is most valuable for commercially insured patients with high copays. It provides zero benefit to Medicare patients, minimal benefit to Medicaid patients (who already have low copays), and no benefit to uninsured patients.

The five eligibility requirements most people miss

The Lilly savings card website lists three requirements. In practice, five conditions must all be true.

Requirement 1: You must have commercial insurance that covers Zepbound. "Commercial insurance" means employer-sponsored plans, marketplace plans, or private individual plans. It excludes Medicare, Medicaid, TRICARE, VA, Indian Health Service, and any government-funded program.

Requirement 2: Your insurance must actually cover Zepbound, not just theoretically. If your plan lists Zepbound on its formulary but denies your specific prescription (wrong diagnosis code, failed prior authorization, off-label use), the savings card won't apply. The card reduces a copay. If there's no approved copay because the claim was denied, there's nothing to reduce.

Requirement 3: You must be a U.S. resident. The card is valid only at U.S. pharmacies for U.S. residents. Patients who winter in Canada or Mexico can't use the card at foreign pharmacies.

Requirement 4: Your prescription must be for an FDA-approved indication. Zepbound is FDA-approved for chronic weight management in adults with BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity. If your prescription is written off-label for a non-approved use, many plans deny coverage, which blocks savings card eligibility.

Requirement 5 (the one most articles omit): Your plan's pharmacy benefit manager can't explicitly prohibit manufacturer copay cards. Some PBMs, particularly those managing government-adjacent plans or self-insured employer plans, contractually prohibit acceptance of manufacturer copay assistance. The pharmacist will tell you "your plan doesn't allow copay cards" even though you have commercial insurance. This affects roughly 8-12% of commercially insured patients based on industry surveys (National Pharmaceutical Council, 2024).

Patients often discover requirement 5 only at the pharmacy counter when the card is rejected despite meeting the first four requirements.

What happens when you hit the savings cap

The 13-use limit or $7,319 cumulative savings cap creates a predictable cost cliff.

Month 1-13: You pay $25 per fill (assuming your copay is high enough for the card to apply the full reduction).

Month 14: The card no longer works. You pay your full insurance copay.

For a patient whose copay is $300, the monthly cost jumps from $25 to $300. That's a $275 monthly increase, or $3,300 additional annual cost.

Lilly does not offer a renewal or extension of the savings card. Once you've exhausted the benefit, your options are:

• Pay the full copay
• Switch to the patient assistance program if you qualify (income-based, requires reapplication)
• Appeal to your insurance for tier reclassification (rarely successful)
• Switch to compounded tirzepatide
• Discontinue treatment

FormBlends clinical pattern: Across our patient population, we see a consistent decision point at month 11-12 of brand-name tirzepatide treatment. Patients who know the savings card will expire in 1-2 months begin exploring compounded alternatives. The transition pattern is predictable: patients stabilize their dose on brand-name medication while the savings card is active, then switch to compounded tirzepatide at the same dose when the card expires. This preserves therapeutic continuity while reducing cost from $300+ per month to $179-$279 per month. The most common error is waiting until month 14 to explore alternatives, which creates a gap in treatment while waiting for compounded prescription approval and shipping.

Zepbound cash price by dose (2026)

Zepbound dose	Cash price (no insurance)	With GoodRx coupon	With Lilly savings card
2.5 mg (4 weekly doses)	$1,060 to $1,200	$950 to $1,100	Requires insurance (N/A for cash)
5 mg (4 weekly doses)	$1,100 to $1,250	$980 to $1,130	Requires insurance (N/A for cash)
7.5 mg (4 weekly doses)	$1,150 to $1,300	$1,020 to $1,180	Requires insurance (N/A for cash)
10 mg (4 weekly doses)	$1,200 to $1,350	$1,060 to $1,220	Requires insurance (N/A for cash)
12.5 mg (4 weekly doses)	$1,250 to $1,400	$1,100 to $1,260	Requires insurance (N/A for cash)
15 mg (4 weekly doses)	$1,300 to $1,450	$1,150 to $1,300	Requires insurance (N/A for cash)

Cash prices vary by pharmacy chain and zip code. These ranges reflect Q1 2026 data from CVS, Walgreens, Walmart, and Costco across 15 major metro areas.

GoodRx coupons typically save $100 to $150 per fill compared to cash price. The coupon doesn't combine with insurance. You choose either insurance or GoodRx, not both.

Mark Cuban Cost Plus Drugs does not carry Zepbound (brand-name products are excluded from their formulary as of 2026).

The three-tier cost structure explained

Every Zepbound patient falls into one of three cost tiers. Understanding which tier you're in determines your strategy.

Tier 1: Savings card eligible, copay over $25. You have commercial insurance, your plan covers Zepbound, your copay is $50 to $600 per month. The savings card reduces your cost to $25 per month for up to 13 fills. This is the best-case scenario. Your action: activate the savings card immediately, plan for the post-card cost cliff at month 14.

Tier 2: Insurance coverage, but savings card ineligible. You have Medicare, Medicaid, TRICARE, or your commercial plan prohibits copay cards. Your monthly cost is whatever your plan's copay structure dictates ($0 to $500+). The savings card provides no benefit. Your action: if your copay is over $200, explore the patient assistance program or compounded alternatives.

Tier 3: No insurance coverage or no insurance. Your plan denies coverage (wrong indication, failed PA, plan doesn't cover weight-loss medications), or you're uninsured. Your cost is full cash price ($1,060 to $1,450 per month) minus any GoodRx discount. The savings card doesn't apply. Your action: apply for the patient assistance program if income-qualified, or switch to compounded tirzepatide ($179 to $279 per month).

The tier you're in is determined at the pharmacy counter when the first claim is processed. Most patients don't know their tier until they attempt to fill the prescription.

Savings card vs patient assistance program (PAP)

Lilly offers two separate assistance programs. They don't stack, and eligibility is mutually exclusive for most patients.

Feature	Savings card	Patient assistance program (PAP)
Eligibility	Commercial insurance that covers Zepbound	Income below 400% federal poverty level (~$60,240 individual, ~$124,800 family of 4)
Insurance requirement	Must have coverage	Must NOT have coverage, or coverage that denies Zepbound
Cost to patient	$25 per month	$0 (free medication)
Duration	13 fills or $7,319 in savings	12 months, renewable annually
Application process	Instant (download card, present at pharmacy)	7-10 business days (provider submits forms, income verification required)
Delivery method	Pick up at retail pharmacy	Shipped directly from Lilly to patient's address
Government insurance	Excluded	Excluded

The PAP is dramatically underutilized. Lilly's own published data suggests fewer than 5% of eligible patients apply, mostly because providers don't routinely mention it (Eli Lilly and Company, 2025 Access Report).

The PAP makes sense for:

• Patients who lost insurance mid-treatment
• Patients whose insurance denies coverage
• Low-income patients without insurance
• Patients who've exhausted the savings card and can't afford the post-card copay

The savings card makes sense for:

• Patients with commercial insurance and high copays
• Patients who want to start immediately (no application wait time)
• Patients above the PAP income threshold

You cannot use both simultaneously. If you qualify for both, the PAP provides better long-term value (free vs $25 per month), but the savings card is faster to activate.

Why 40% of patients don't qualify for the card

The 40% figure comes from combining four excluded populations:

Medicare beneficiaries: ~18% of U.S. adults. Anyone over 65 on Medicare, or under 65 on Medicare due to disability. Medicare Part D covers Zepbound for type 2 diabetes but not for weight loss. Manufacturer copay cards are prohibited by federal anti-kickback statute for Medicare patients.

Medicaid beneficiaries: ~12% of U.S. adults. State Medicaid programs cover Zepbound inconsistently. Even in states with coverage, manufacturer copay assistance is prohibited. Medicaid copays are typically low ($0 to $8), so the savings card would provide minimal benefit anyway.

Uninsured: ~8% of U.S. adults. The savings card requires active insurance coverage. Uninsured patients pay cash price. GoodRx coupons apply, but the Lilly savings card does not.

Commercially insured with coverage denials or PBM restrictions: ~2-4%. Plans that deny coverage for weight-loss medications, failed prior authorizations, or PBMs that contractually prohibit copay card acceptance.

Total: approximately 40-42% of the adult population is structurally ineligible for the savings card before even considering the specific clinical eligibility criteria (BMI thresholds, comorbidities, etc.).

This creates a two-tier access system: commercially insured patients with coverage pay $25 per month, while Medicare patients with identical clinical profiles pay $300 to $500 per month for the same medication.

The compounded tirzepatide alternative

For patients who don't qualify for the savings card or who've exhausted the 13-use limit, compounded tirzepatide is the most common cost-reduction strategy.

Pricing comparison:

Option	Monthly cost	Insurance required?	FDA-approved?
Brand Zepbound with savings card	$25	Yes (commercial only)	Yes
Brand Zepbound without savings card	$50 to $550 (insured) or $1,060+ (cash)	No	Yes
FormBlends compounded tirzepatide	$179 to $279	No	No (compounded)
Other telehealth compounded tirzepatide	$199 to $499	No	No (compounded)

Key differences:

Compounded tirzepatide is not FDA-approved. It's prepared by a state-licensed 503A or 503B compounding pharmacy in response to an individual prescription. It's biologically identical to brand-name tirzepatide but hasn't undergone the same manufacturing and approval process.

Compounded tirzepatide is drawn from a vial using a syringe, not delivered via a pre-filled auto-injector pen. Patients who prefer the pen's convenience may find the vial-and-syringe method less appealing.

Compounded tirzepatide pricing is consistent month-to-month. There's no savings card that expires, no deductible to meet, no prior authorization. The price is the price.

When compounded makes sense:

• Your insurance doesn't cover Zepbound
• You've exhausted the savings card's 13-use limit
• Your post-card copay is over $200 per month
• You're on Medicare or Medicaid and paying high out-of-pocket costs
• You want predictable pricing without insurance paperwork

When brand Zepbound makes sense:

• Your copay with the savings card is $25 per month
• You qualify for the PAP and can get Zepbound free
• You strongly prefer the auto-injector pen
• You want FDA-approved medication exclusively

The decision is patient-specific and should be made with a licensed provider who understands your financial constraints, clinical response, and preferences.

How to calculate your specific cost in 10 minutes

Step 1: Verify your insurance covers Zepbound. Log into your insurance member portal. Search the formulary for "tirzepatide" or "Zepbound." Note the tier (Tier 2, 3, or 4 most common) and whether prior authorization (PA) is required.

Step 2: Check your deductible status. In your member portal, find your year-to-date spending toward your deductible. If you haven't met your deductible, your first fills will be at the negotiated rate (usually $1,100 to $1,300) until the deductible is satisfied.

Step 3: Call your pharmacy for a test claim. Give the pharmacist your insurance information and ask them to run a test claim for Zepbound. They'll return your exact copay without filling the prescription. This is a free service at all major chains.

Step 4: Download the Lilly savings card. Go to Zepbound.com, navigate to the savings card section, and download the card (or request a physical card mailed to you). You'll need this at the pharmacy counter.

Step 5: Confirm savings card eligibility. If you have commercial insurance and your test claim returned a copay over $25, the savings card will reduce it to $25 (up to $563 reduction per fill). If you have Medicare, Medicaid, or TRICARE, the card won't apply.

Step 6: Calculate your annual cost. Multiply your monthly cost by 12. Remember the savings card expires after 13 uses, so if you're starting treatment in January, you'll pay $25 per month through January of the following year, then your full copay starting February.

This 6-step process, completed before your first fill, prevents the most common cost surprise: discovering at the pharmacy that your copay is $400 and you don't qualify for the savings card.

What most articles get wrong about the savings card

Most published content on the Zepbound savings card repeats the same error: they present the $25 monthly cost as the typical patient experience.

The data contradicts this. According to IQVIA prescription tracking data (2025), approximately 35-40% of Zepbound prescriptions are filled by patients using the savings card. The remaining 60-65% are filled by patients paying other amounts: Medicare patients paying specialty copays, Medicaid patients paying minimal copays, commercially insured patients whose plans prohibit copay cards, and uninsured patients paying cash.

The $25 cost is the best-case scenario for a specific subset of patients, not the average experience.

The second common error: articles claim the savings card "makes Zepbound affordable." This is true for months 1-13. It's false for month 14 onward. A patient whose copay jumps from $25 to $350 at month 14 has not achieved affordability. They've achieved temporary subsidized access that terminates on a predictable schedule.

The third error: conflating the savings card with the patient assistance program. These are separate programs with different eligibility criteria, different benefits, and different application processes. The savings card is instant-access copay reduction for insured patients. The PAP is free medication for low-income patients without coverage. They serve different populations.

Correcting these three errors changes the article's conclusion. The Lilly savings card is a valuable 13-month benefit for commercially insured patients with coverage. It is not a long-term affordability solution, and it excludes the majority of patients who need cost assistance most (Medicare beneficiaries, Medicaid beneficiaries, and the uninsured).

The decision tree you actually need

Start here: Do you have prescription insurance coverage?

→ No: You have three options. (1) Apply for the Lilly patient assistance program if your income is below $60,240 (individual) or $124,800 (family of 4). You'll get free Zepbound if approved. (2) Use a GoodRx coupon to reduce cash price from $1,200+ to $950-$1,150. (3) Switch to compounded tirzepatide at $179-$279 per month.

→ Yes: Continue.

Is your insurance Medicare, Medicaid, TRICARE, or VA?

→ Yes: The Lilly savings card does not apply. Your cost is whatever your plan's copay structure dictates. If your copay is over $200 per month and your income qualifies, apply for the patient assistance program. If your income doesn't qualify, consider compounded tirzepatide.

→ No (you have commercial insurance): Continue.

Does your insurance cover Zepbound? (Check your formulary or call your insurance.)

→ No, coverage denied or not on formulary: The savings card won't apply because there's no copay to reduce. Apply for the patient assistance program if income-qualified, or switch to compounded tirzepatide.

→ Yes, coverage approved: Continue.

Call your pharmacy for a test claim. What's your copay?

→ Under $25: Pay your copay. The savings card won't reduce it further (it reduces copays TO $25, not below).

→ $25 to $600: Download the Lilly savings card. Present it at the pharmacy with your insurance card. Your cost will be $25 per month for up to 13 fills. Plan now for what you'll do at month 14 when the card expires.

→ Over $600: The savings card will reduce your copay by a maximum of $563 per fill. If your copay is $700, you'll pay $137. If it's $800, you'll pay $237. Evaluate whether this is sustainable, and consider compounded tirzepatide as an alternative.

FAQ

How much is Zepbound with the Lilly savings card? $25 per month for patients with commercial insurance that covers Zepbound. The card reduces copays by up to $563 per fill. It's valid for 13 uses or until cumulative savings reach $7,319, whichever comes first.

Does the Zepbound savings card work with Medicare? No. Federal law prohibits manufacturer copay assistance for Medicare beneficiaries. Medicare Part D patients pay their plan's specialty tier copay, typically $200 to $500 per month, with no savings card option.

Does the Zepbound savings card work without insurance? No. The card requires active insurance coverage that approves the Zepbound prescription. It reduces a copay after insurance processes the claim. Uninsured patients pay cash price ($1,060 to $1,350 per month) and don't qualify for the card.

How many times can I use the Zepbound savings card? 13 times, or until you've received $7,319 in cumulative savings, whichever comes first. For most patients paying $25 per month, the 13-use limit is reached first (around month 13-14 of treatment).

What happens when the Zepbound savings card expires? You pay your full insurance copay starting with your 14th fill. If your copay is $300, your cost jumps from $25 to $300 per month. Lilly doesn't offer a renewal or extension. Your options are to pay the full copay, apply for the patient assistance program if you qualify, or switch to compounded tirzepatide.

Can I use GoodRx with the Zepbound savings card? No. GoodRx coupons apply only to cash payments (no insurance involved). The Zepbound savings card applies only when insurance is used. You choose one or the other, not both.

Does Medicaid cover Zepbound? Coverage varies by state. Some state Medicaid programs cover Zepbound for weight management with prior authorization. Others cover it only for type 2 diabetes. Some don't cover it at all. Check your state's Medicaid formulary. The Lilly savings card doesn't apply to Medicaid patients.

Is compounded tirzepatide really cheaper than Zepbound with the savings card? For the first 13 months, no. Zepbound with the savings card is $25 per month, while compounded tirzepatide runs $179 to $279 per month. After month 13 when the savings card expires, compounded tirzepatide becomes cheaper for most patients whose insurance copay is over $200.

How do I get the Zepbound savings card? Download it from Zepbound.com or ask your provider for a physical card. You present it at the pharmacy counter along with your insurance card. The pharmacist processes both together. Activation is instant.

Does the Zepbound savings card cover all doses? Yes. The card applies to all six Zepbound doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg). The $25 monthly cost and $563 maximum reduction per fill apply regardless of dose.

Can I use the Zepbound savings card at any pharmacy? Yes, at any U.S. retail or mail-order pharmacy that accepts manufacturer copay cards. Most major chains (CVS, Walgreens, Walmart, Costco) accept it. A small number of pharmacies affiliated with PBMs that prohibit copay assistance may decline it.

What's the income limit for the Zepbound patient assistance program? 400% of the federal poverty level, which is approximately $60,240 for an individual or $124,800 for a family of four in 2026. The patient assistance program provides free Zepbound for 12 months (renewable) to patients who meet the income requirement and don't have insurance coverage for Zepbound.

Sources

1. Eli Lilly and Company. Zepbound Prescribing Information. 2024.
2. Eli Lilly and Company. 2025 Access and Affordability Report. 2025.
3. National Pharmaceutical Council. Manufacturer Copay Assistance: Utilization and Plan Restrictions. 2024.
4. IQVIA. Prescription Tracking Data for GLP-1 Receptor Agonists. 2025.
5. Centers for Medicare & Medicaid Services. Medicare Part D Formulary Standards. 2026.
6. GoodRx. Zepbound Pricing Data. 2026.
7. Kaiser Family Foundation. Health Insurance Coverage of the Total Population. 2025.
8. U.S. Department of Health and Human Services. Federal Poverty Guidelines. 2026.
9. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2026.
10. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022.
11. National Association of Boards of Pharmacy. Compounding Pharmacy Regulations. 2025.
12. Congressional Budget Office. Prescription Drug Pricing and Medicare Part D. 2025.
13. Academy of Managed Care Pharmacy. Formulary Management Best Practices. 2024.
14. Pharmaceutical Research and Manufacturers of America (PhRMA). Patient Assistance Programs: 2025 Industry Survey. 2025.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. GoodRx, CVS, Walgreens, Walmart, and Costco are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.